Adherence to federal guidelines for reporting of sex and race/ethnicity in clinical trials.

@article{Geller2006AdherenceTF,
  title={Adherence to federal guidelines for reporting of sex and race/ethnicity in clinical trials.},
  author={S. Geller and M. Adams and M. Carnes},
  journal={Journal of women's health},
  year={2006},
  volume={15 10},
  pages={
          1123-31
        }
}
  • S. Geller, M. Adams, M. Carnes
  • Published 2006
  • Medicine
  • Journal of women's health
    • BACKGROUND The National Institutes of Health Revitalization Act of 1993 requires that NIH-funded clinical trials include women and minorities as subjects; other federal agencies have adopted similar guidelines. The objective of this study was to determine the current level of compliance with these guidelines in federally funded randomized controlled trials. METHODS Randomized controlled trials published in nine influential medical journals in 2004 were identified by PubMed search. Studies… CONTINUE READING
    View PDF
    112 Citations
    Highly Influencial Citations
    4
    Background Citations
    39
    Methods Citations
    4
    Results Citations
    1
    112 Citations
    Citation Type

    Citation Type

    Inclusion, analysis, and reporting of sex and race/ethnicity in clinical trials: have we made progress?
    • 221
    • PDF
    The More Things Change, the More They Stay the Same: A Study to Evaluate Compliance With Inclusion and Assessment of Women and Minorities in Randomized Controlled Trials
    • 32
    • PDF
    After inclusion, information and inference: reporting on clinical trials results after 15 years of monitoring inclusion of women.
    • 25
    Inclusion of women and gender-specific analyses in randomized clinical trials of treatments for depression.
    • 37
    Sex and race/ethnicity reporting in clinical trials: a necessity, not an option.
    • 8
    • Highly Influenced
    Exclusion of women from clinical research: myth or reality?
    • 30
    Doubly blind: a systematic review of gender in randomised controlled trials
    • PDF
    Doubly blind: a systematic review of gender in randomised controlled trials
    • 59
    • PDF
    Gender Bias in Studies for Food and Drug Administration Premarket Approval of Cardiovascular Devices
    • 68
    Considerations of sex and gender differences in preclinical and clinical trials.
    • 28

    References

    SHOWING 1-10 OF 19 REFERENCES
    Gender bias in clinical trials: do double standards still apply?
    • 83
    Adequacy of reporting race/ethnicity in clinical trials in areas of health disparities.
    • 76
    Women subjects in NIH-funded clinical research literature: lack of progress in both representation and analysis by sex.
    • 128
    Participation in cancer clinical trials: race-, sex-, and age-based disparities.
    • 1,387
    • PDF
    Publication bias in clinical research
    • 2,556
    Tracking publication outcomes of National Institutes of Health grants.
    • 35
    Sex Differences in Antidepressant Response in Recent Antidepressant Clinical Trials
    • 161
    Gender differences in symptoms associated with acute myocardial infarction: a review of the research.
    • 89
    Sex-based differences in the effect of digoxin for the treatment of heart failure.
    • 556
    Invited commentary: "race," racism, and the practice of epidemiology.
    • C. P. Jones
    • Medicine
    • American journal of epidemiology
    • 2001
    • 305
    • PDF